Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Finance

LSP to deploy $600M fund to retain larger stakes in early-stage European biotechs

New fund to target €25-€30M per company, with focus on European therapeutics and med-tech companies

March 10, 2020 10:57 PM UTC

LSP has formally closed its sixth fund at $600 million, the largest ever for a European life sciences fund. The firm joins a growing number of European VCs that have announced record fund-raisings in recent years, signaling increased funding opportunities for innovation coming out of European labs.

Last year LSP had a first close of the fund at €465 million ($519 million), already surpassing its final target of $450 million. The firm said it has a total of $1.1 billion to invest across LSP 6, LSP's Health Economics fund and its public fund. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article